Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Jacqueline Nguyen

Physician Assistant Frisco, TX Physician Assistant

NPI 1275022915 CMS profile 10639781

5375 Coit Rd Ste 130, Frisco, TX 75035

Open in the dashboard

General payments

$10,143

516 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jacqueline Nguyen of Frisco, TX is reported in the CMS Open Payments database as having received $10,143 across 516 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,883 91
2024 General $2,069 99
2023 General $2,285 112
2022 General $2,308 124
2021 General $1,598 90

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jacqueline Nguyen
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Jacqueline Nguyen were reported at $1,883. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Jacqueline Nguyen Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $1,598 $132 $37–$438 $132
2022 $2,308 $155 $48–$522 $149
2023 $2,285 $167 $52–$557 $160
2024 $2,069 $178 $55–$600 $164
2025 $1,883 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $1,604 101 payments
  2. Biogen, Inc. $704 33 payments
  3. UCB, Inc. $619 25 payments
  4. Novartis Pharmaceuticals Corporation $444 26 payments
  5. Amgen Inc. $398 18 payments
  6. Teva Pharmaceuticals USA, Inc. $371 20 payments
  7. ACADIA Pharmaceuticals Inc $350 17 payments
  8. Biohaven Pharmaceutical Holding Company Ltd. $342 20 payments
  9. Celgene Corporation $335 18 payments
  10. Pfizer Inc. $330 26 payments
  11. Other $4,647 212 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $10,143 516 payments
Products named General payments · program years 2021–2025
  1. QULIPTA $869 57 payments
  2. UBRELVY $716 48 payments
  3. NURTEC ODT Primary Care $584 30 payments
  4. BOTOX $507 29 payments
  5. Briviact $414 18 payments
  6. TYSABRI $404 18 payments
  7. AIMOVIG $389 19 payments
  8. ZEPOSIA $383 19 payments
  9. Austedo XR $313 16 payments
  10. NURTEC ODT Pain $311 25 payments
  11. Other $6,589 319 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

516 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record